Patent Grant
11064989
Not Applicable.
This application relates to an engineered, adaptable, predictable supporting device/system that can be used to displace, reposition, retract, secure and/or stabilize excess and/or redundant tissue both during a medical/surgical procedure and for an extended period of time after the procedure to maintain such excess tissue away from a wound (such as a surgical incision) initially to facilitate the procedure and subsequently to facilitate healing of the wound. The excess or redundant tissue can be adipose tissue (such as on the neck, legs, back, sides, etc.), breast tissue, panniculus tissue, etc. The device can be termed a retractor/wound exposure assist device.
A significant portion of surgical patients present to the operating room with a BMI (Body Mass Index) over 30. People with a BMI over 30 are considered to be obese, and will commonly have a panniculus (or layer/apron of fat which hangs from the abdomen). Depending on how obese the individual is, the panniculus (or adipose layer or fatty layer) can extend to the pubic hair line (in smaller panniculi) or to the knees and beyond (in very large panniculi). This situation has been arising more frequently in recent years due to a greater number of people being morbidly obese than in years past. Many of these individuals accumulate a large mass of adipose (fatty tissue) in the lower abdominal area producing a panniculus (apron of fat) that hangs, depending on its size, over abdominal wounds, and depending on the size or severity of the panniculus, can hang over the groin, genital area, or upper thighs.
Patients with such large BMIs require the clinical staff to manage excessive amounts of adipose (or fatty tissue), skin and other tissues both during medical procedures (to facilitate the procedure) and after the medical procedure (to facilitate healing of any incisions). In addition to the panniculus, the excess or redundant tissue can also include breast tissue, or adipose tissue in the neck, back, leg, or sides of the patient. In U.S. Pat. No. 9,427,222, which is incorporated herein by reference, we disclose a retractor system which can be used to retain excessive or redundant tissue away from a surgical site. However, the retractor system of U.S. Pat. No. 9,427,222 was initially designed for use during a surgical procedure. In WO2016/122892, which is also incorporated herein by reference, we disclose a wound exposure device that is designed for application after a surgical procedure, and after any retractors that had been used have been removed. As can be appreciated, if a wound exposure device is used that is separate from the retractor, the retractor will need to be removed from the patient and then the wound exposure device applied to the patient. The removal of one device and application of a second device could irritate the patient's skin. Further, application of a second device would require the clinical staff to engage in two retracting procedures—the first, during application of the retractor, and the second during application of the wound exposure device. However, in view of the fact that the retractor disclosed in U.S. Pat. No. 9,427,222 (which is commercially available from GSquared Medical LLC of Brentwood, Tenn. under the name Retentus®) is already applied to the patient, it would be desirable to provide a retractor which can also function as a wound exposure device to retain the adipose tissue in a retracted position after a surgical procedure to facilitate healing of any incisions, punctures or wounds.
Briefly stated, A multi-ply adhesive device to retract excess or redundant tissue from an incision site on a patient prior to a medical/surgical procedure, and to then maintain the excessive/redundant tissue away from the incision site after the medical/surgical procedure to facilitate healing of the incision site. The device comprises a top layer, a backing layer and a middle layer between the top and backing layers; the middle layer being comprised of at least one middle ply and having a middle layer top surface and a middle layer bottom surface, the at least one middle ply being stretchable. A middle-ply adhesive is applied to substantially the entirety of the middle layer bottom surface to removably adhere the backing layer to the middle layer bottom surface.
The device includes at least one bottom ply tab which is integral with the device. The bottom ply tab comprises an inner edge defined by a cut extending through the top and middle layers such that when the at least one bottom ply tab is pulled away from the top and middle layers, at least a portion of the backing layer will be removed from the middle layer to expose the adhesive of the middle layer.
Additionally, the device includes at least one top ply tab integral with the device. The at least one top ply tab comprises an inner edge defined by a cut extending through the bottom and middle layers such that when the top ply tab is pulled away from the bottom and middle layers, at least a portion of the top layer will be removed from the middle layer.
The device can include any of the following features in any desired combination.
In accordance with an aspect of the device, the middle ply adhesive is a gel adhesive, such as a silicone adhesive or a co-adhesive.
In accordance with an aspect of the device, the top ply is adhered to the middle ply without adhesive.
In accordance with an aspect of the device, the top ply is adhered to the middle ply with a top-ply adhesive which substantially covers a bottom surface of the top ply. This top-ply adhesive can be an acrylate adhesive or a co-adhesive.
In accordance with an aspect of the device, the device can include at least one “press” area at an edge of the device. The “press” area, if provided, is defined by a top cut such that the top ply of the “press” area is not connected to the top ply of the remainder of the body; such that, during use, the “press” area can be pressed against while the top ply tab is used to remove the top ply from the device to reduce the possibility of the middle ply from lifting off a patient during removal of the top ply.
In accordance with an aspect of the device, the back ply is made from a material which is substantially non-stretchable. The back ply can be made from a paper or from an LDPE, PET or poly film
In accordance with an aspect of the device, the top and middle layers are polymers, and the middle layer is more stretchable than the top layer. In a preferred embodiment, the top layer is substantially not stretchable and the middle layer is highly stretchable.
In accordance with an aspect of the device, top layer is substantially fluid impermeable.
In accordance with an aspect of the device, the middle layer is air permeable.
In accordance with an aspect of the device, the top ply tab at least partially overlaps the bottom ply tab.
In accordance with an aspect of the device, the device comprises a lower body portion and an upper anchor point portion.
In accordance with an aspect of the device, the backing layer of the body portion has a plurality of back cuts, such that the backing layer defines a plurality of panels. The device includes a bottom ply tab for each of the backing layer panels. Preferably, at least two of the plurality of panels of the backing layer extend have a side-to-side width which, at least in part, is equal to the side-to-side width of the device.
In accordance with an aspect of the device, the device includes stretch features which allow the device to be stretched during application of the device to a patient before removal to the top layer of the device. The stretch feature includes a perforated line which extends through just the top layer and extends the width of the device. The perforated line divides the top layer of the device into a top layer lower portion and a top layer upper portion. The perforated line can be broken by pulling the upper portion of the device away from the lower portion to enable the middle layer of the device to be selectively stretched during application of the device to a patient. In this embodiment, the at least one top layer tab includes a first top layer tab associated with the top layer below the perforated line and a second top layer tab associated with the top layer above the perforated line. This embodiment of the device can be provided with a tension gauge for measuring the amount of tension applied to the device when the middle layer is pulled. In one example, the tension gauge comprises a tongue extending from the top ply lower portion into the top ply upper portion and tension indicia on the top ply upper layer adjacent the tongue; the indicia indicating the amount of tension applied to the middle layer.
In accordance with another aspect of the device, the device is formed from a single piece of multi-ply material.
In accordance with an aspect of the device, the device is formed from at least a first and a second piece of material. In an illustrative embodiment, the device is formed from a bottom section, a mid-section, and a top section which are joined together, wherein at least the mid-section is formed from a material which is different than the material from which the top and bottom sections are formed. The top and bottom sections can be formed from the same material or from different materials. The mid-section, in this embodiment, can be void of adhesive on the bottom surface of the mid-section.
In accordance with an aspect of the device, the device includes at least one top cut which divides the top ply into at least two top ply panels, and wherein the device further includes a top-ply tab associated with each top ply panel to remove the top-ply panels from the middle ply.
In accordance with an aspect of the device, the device includes a middle ply cut which extends only through the middle ply. Preferably, the middle ply cut extends across the device proximate the bottom edge of the device.
In accordance with an aspect of the device, the device includes at least one indicator/sensor adapted to monitor a parameter chosen from the group consisting of elongation and/or stretch of the retractor/stabilizer, and ambient and physiological aspects of the patient's wound. The indicator/sensor is adapted to indicate if the monitored parameter exceeds or falls below a predetermined threshold. If the indicator/sensor monitors elongation/stretch of the retractor/stabilizer, the indicator/sensor can be a mechanical indicator incorporated into the retractor/stabilizer. Regardless of the parameter being monitored, the indicator/sensor can transmit to a receiver a signal indicative of the parameter being monitored. Such transmission can be wireless or via direct electrical connection.
Corresponding reference numerals will be used throughout the several figures of the drawings.
The following detailed description illustrates the claimed invention by way of example and not by way of limitation. This description will clearly enable one skilled in the art to make and use the claimed invention, and describes several embodiments, adaptations, variations, alternatives and uses of the claimed invention, including what we presently believe is the best mode of carrying out the claimed invention. Additionally, it is to be understood that the claimed invention is not limited in its application to the details of construction and the arrangements of components set forth in the following description or illustrated in the drawings. The claimed invention is capable of other embodiments and of being practiced or being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting.
A first illustrative embodiment of a retractor/wound exposure device 10 is shown in
The bottom ply 12 is preferably a release liner, and can be made, for example, of a substantially non-stretchable material, such as Kraft paper. The liner can also be a PET or other polymer film. The middle ply 14 is preferably a material that is stretchable, and preferably, substantially stretchable, in at least one direction. The middle ply could, for example, be a polymer film, or could be a material that has an elastic component, such as Spandex® The top ply 16 is preferably made from a polymer film different from the middle ply and which has at best only slight stretchability. The middle ply has a lower surface coated with a hypoallergenic pressure sensitive adhesive (such as an acrylic, acrylate, or silicone adhesive) to removably secure the bottom ply release liner 12 to the middle ply 14. The top ply 16 is adhered to the middle ply 14 without the use of an adhesive. For example, the top ply 16 can self-adhere to the middle ply 14 by means of co-adhesion. A preferred material for the retractor/wound care device 10 is 3M 9836 medical tape (available from 3M). In this tape, the bottom ply 12 is comprised of a non-stretchable silicone coated paper, which is, for example, about 5 mil (about 0.127 mm) thick. The middle ply 14 is a polyethylene film having an acrylic adhesive applied to a bottom side thereof, to removably secure the bottom ply to the middle ply. The middle ply is highly conformable and is stretchable, having a percentage of elongation/stretchability of approximately 5%-500%. Additionally, this middle ply is typically breathable, and preferably has a high vapor transmission rate (VTR), from about 500 to about 8000 g/m2/24 hrs. The middle ply can have a thickness of about 1 mil (about 0.03 mm). The top ply can be a polyolefin film with a thickness of about 2.5 mil (about 0.06 mm). The top ply can be slightly stretchable, but in any event has a stretchability less than the stretchability of the middle ply. For example, the top ply can have a low to moderate elongation/stretchability percentage, such as from zero to about 500%. As such, the top ply can be substantially non-stretchable. The top ply is liquid impermeable, and is also preferably air impermeable. The overall device as-supplied (liner ply, middle ply, and top ply) has a thickness of about 7.5 mil (about 0.2 mm). When the bottom (liner) layer 12 is still adhered to the middle ply 14, the device is substantially not stretchable.
Turning back to
As described below, the device 10 is provided with a plurality of bottom ply tabs 30, 48, 74a which enable the paper ply 12 to be removed from the middle ply 14 in several pieces to thereby expose the adhesive of the middle ply for application of the device 10 to a patient. In addition, the device includes top ply tabs 62 to enable removal of the top ply 16 from the middle ply 14 after application of the device 10 to a patient.
The yoke 24 includes a back cut 44 which extends at a slight cant from the center of the U-shaped edge 42 toward the yoke edges 38. Additional concave bottom cuts (BC) 46 at the ends of the arms 36 have opposite ends along the yoke upper edge 40. An A-tab 48 extends outwardly from each yoke edge 38, and is defined in part by an inner top-middle cut 50 which is co-linear with the yoke edge 38. Additionally, a B-tab 52 extends from each top edge 40 of the yoke between the ends of the top-middle cuts 46. The inner edges of the B-tabs 52 are defined by top-middle cuts 54. As such, the A- and B-tabs are bottom ply tabs which remove their associated portions of the bottom ply or liner from the middle ply.
The device 10 includes a series of cuts along the bottom edge of the body 20 that form five sections/tabs as follows: a center bottom ply C-tab 60, two top ply E-tabs 62a,b, and two outer finger press areas 64. These tabs/sections are defined by four full cuts 66a-d which extend upwardly generally perpendicularly from the bottom edge 30 of the body 20. The full cuts fully separate the tabs 60, 62a,b and sections 64a,b from each other. The top edge of the middle or C-tab 60 is defined by a top-middle cut (TMC) 67 which extends generally parallel to the bottom edge 30 and between the full cuts 66b and 66c. The top edge of the E-tabs 62 are defined by bottom-middle cuts (BMC) 68 which extend between the full cuts 66a and 66b on one side of the device and 66c and 66d on the other side of the device. Finally, top cuts (TC) 70 extend diagonally downwardly from the side edges 32 of the body 10 to the top ends of the full cuts 66a and 66d to define top edges of the finger press areas 64 of the body 20. In addition, large arced bottom cuts (BC) 72 extend from the tops of the full cuts 66b,c to the edges 32 of the body 20 to define bottom corner panels of the bottom ply. Finally, bottom ply D-tabs 74 extend outwardly from the side edges 32, with the top edges of the tabs 74 being level with or below the point where the bottom cuts 72 intersect the side edges 32. The inner edges of the tabs 74 are defined by top-middle cuts (TMC) 76 which are co-linear with the side edge 32 of the body 20.
The inner edges of the A-, B-, C- and D-tabs 48, 52, 60, and 74, respectively, are defined by top-middle (TMC) cuts, so that the top and middle plies of the tabs are separated from the top and middle plies of the rest of the device. Thus, when these tabs are pulled, they will pull the backing or bottom ply 12 away from the middle ply 14 to expose the adhesive on the middle ply. Hence, they are, as noted, bottom ply tabs. The inner edge of the E-tabs 62 are defined by bottom-middle cuts 68, and thus separate the bottom and middle plies on the tabs from the bottom and middle plies of the rest of the device. Therefore, when the E-tabs 62 are pulled, they will lift the top ply 16 off of the middle ply 14. Hence, the E-tabs, as noted, are top ply tabs.
The A-E tabs define two types of tabs. The A-tabs 48, B-tabs 52, and the D-tabs 74 extend from the edge of the device, and are thus considered outboard tabs. The C-tab 60 and E-tabs 68, on the other hand, have outer edges which are commensurate, flush, or even with the edge of the device. That is, they do not protrude from the edge of the device as do the A-, B- and D-tabs. The C- and E-tabs are thus considered inboard tabs. The device could be formed with all the tabs being inboard tabs, all the tabs being outboard tabs, or with both inboard and outboard tabs, as shown. In this latter instance, any selected group of the A-E tabs could be inboard tabs, and the remaining tabs would then be outboard tabs.
To apply the device 10 to a patient, the patient is preferably supine. The A-tabs 48 are initially pulled to peel the backing layer 12 from the yoke 24 (except in the area defined by the cut lines 46) to expose the adhesive of the middle ply 14 of the yoke. The area defined by the cuts 46 thus define gripping or hold areas 76 for the yoke. When the backing of the yoke is removed by pulling the A-tabs, the backing remains in the hand hold areas 76. The yoke is then adhered to an anchor point on the patient to position the device 10 on the patient. When retracting the panniculus, this anchor point is preferably between the patient's upper thorax and xiphoid process. Staff can grip the yoke by the hold areas 76, so that they can handle the yoke without contacting the adhesive in the areas defined by the cuts 46. Once the yoke area has been positioned and adhered to the patient, the staff will manually retract the patient's panniculus toward to the anchor point (in a panniculus retraction, this is a cephalad direction). While holding the panniculus in the retracted position, other staff will hold the device 10 in the corner areas (defined by the cuts 72) and pull the bottom C-tab 60 to remove the bottom ply 12 from the device body 20 (except for the bottom corner panel of the bottom ply defined by the cuts 72) and from the neck 22 to expose the adhesive of the middle ply in the neck and majority of the body. While holding the panniculus in the retracted position, the body 20 and neck 22 of the device 10 are adhered to the patient and smoothed out. Once the body 20 and neck 22 have been adhered to the patient's panniculus, the device 10 will hold the panniculus in the desired retracted position. Staff can thus stop manual retraction of the panniculus. As a last step, staff will remove the backing layer in the bottom corners by pulling on the D-tabs 74. The D-tabs will remove the backing layer from the bottom corners of the body except for the backing of the E-tabs 62. Thus, staff can hold the E-tabs 62 to facilitate removal of the backing in the bottom corners of the body. The corner areas of the body can then be smoothed out over the patient. As can be appreciated, at this point in the application process, the backing layer 12 has been removed from the device except for in the E-tabs and the gripping areas 76. If desired, the B-tabs can be pulled to remove the backing ply from the finger grips 76 at any time after the yoke 24 has been adhered to the patient to adhere the top portion of the yoke to the patient.
With the device 10 now applied to the patient, the patient will have the middle ply 14 and top ply 16 covering the panniculus and holding the panniculus in the retracted position. The top ply 16, as noted above, has little to no stretchability, and thus, the top ply will prevent the panniculus from falling back to a relaxed position. With the panniculus held securely in a retracted position, the medical staff can proceed with the procedure or operation to be performed on the patient. The application process was described with respect to retraction of a patient's panniculus. As noted above, the device can also be used to retract breast tissue or excess adipose tissue in virtually any other part of the body. Application of the device to retract breast tissue or other adipose tissue will be substantially the same as described above. However, as can be appreciated, the anchor point will vary with the area of the tissue to be retracted.
Although the device 10 was described as being applied from the top (yoke) down to the bottom (body), the device 10 could be applied by initially adhering the body 20 to the patient after manual retraction of the panniculus in a cephalad direction, much as described in the above-noted U.S. Pat. No. 9,427,222. When retracting a panniculus, once the body 20 is adhered to the panniculus, the device 10 is pulled toward the anchor point (i.e., in a cephalad direction) to maintain the retraction of the device, and is then adhered to the anchor point, i.e., between the patient's upper thorax and xiphoid process. As can be appreciated, the ability of the device 10 to support the panniculus (or other excess flesh) out of the way of the incision site can enable orthopedic surgeons to perform surgery on higher BMI patients with an anterior approach.
After the procedure has been completed, the patient may have a suture wound or puncture wound which will need to heal. It is thus desirable to maintain the retracted tissue in the retracted position, to facilitate healing of the wound. Because the top ply is relatively thick (i.e., about 2.5 mils) and is a non-breathable film (i.e., not air permeable), it is not ideal for long term wear. By pulling upwardly on the top-ply E-tabs 62, the top ply 16 will be removed from the middle ply 14, so that only the middle ply remains on the patient. The adhesive which holds the middle ply to the patient is relatively weak. Thus, the action of pulling the top ply 16 from the middle ply 14 can cause the middle ply to separate or be pulled from the patient's skin. To prevent this from happening, staff can press down on the corner finger press areas 64 to hold the corners of the middle ply in place, and then pull up on the E-tabs 62 to separate the top ply 16 from the middle ply 14. If staff do not press down in the corner tabs 64, there is a risk that pulling up on the E-tabs would start separating the middle ply from the patient's skin. With the top ply 16 removed, all that remains on the patient is the middle ply 14. As noted above, the middle ply is breathable (i.e., at least air permeable if not also liquid permeable), stretchable, highly conformable, and thin (about 1 mil thick). It is thus more comfortable for the patient to wear long term (i.e., several days or even weeks). The device can thus remain on the patient while the wound heals. Although the middle ply 14 is highly stretchable, it will maintain the panniculus off the wound site, so that the wound is exposed to ambient atmosphere to facilitate healing. Otherwise the panniculus could cover the wound which would hinder healing and potentially result in an infection at the site of the wound.
Once the wound has healed, the remaining middle ply can be removed from the patient. As noted above, the adhesive is a relatively weak adhesive, and by carefully lifting the middle ply from the patient, the remaining middle ply can be removed without substantial trauma to the patient's skin.
Application of the retractor/wound exposure device is described above as being initially applied to the patient pre-operatively. Post operatively, the top ply is then removed. However, in certain circumstances, it may be desirable to apply the device to a patient post-operatively. In this instance, the device is applied as described above. The top ply may be allowed to remain in place for a desired period of time, if the reduced stretchability of the top ply is desired. Alternatively, the top ply can be removed promptly as part of the application process.
The retractor/wound exposure device 10 is a basic device. Various features, described below, can be added to the device in any combination to facilitate application of the device to the patient or to take advantage of the stretchability of the middle ply 14 during application of the device to the patient.
The bottom third of the device 110 is substantially identical to the bottom third of the device 10, and will not be further explained. However, it is noted that in the device 110, the bottom ply tab 160 is an A-tab, the top ply tabs 162 are D-tabs, and the bottom ply tabs 174 are B-tabs.
The device 110 includes a pair of spaced apart (and generally parallel) back cuts (BC) 180 and 182 which extend across the body 120, with the lower back cut 180 being slightly above the B-tabs 174 and the back cut 182 being slightly above the back cut 180. A third back cut 184 extends across the top of the body 120 just below the neck 122. A bottom ply tab 186 (labeled C1) extends from the body edge 132 between the back cuts 180 and 182. The inner edge of the tab 186 is defined by a top-middle cut 186a, such that when the C1-tab 186 is pulled, it will remove the backing layer from the middle ply between the cuts 180 and 182. Thus, the C1 tab will remove a strip of the backing layer. A further bottom ply tab 188 (labeled C2) extends from the body edge 132 above the back cut 182. The inner edge of the tab 188 is defined by a top-middle cut 188a, such that when the C2-tab 188 is pulled, it will remove the backing layer from the middle ply between the back cuts 182 and 184. Hence, the backing ply 12 in the body 120 is removed using the A-tab 160, the B-tabs 174, the C1-tab 186, and the C2-tab 188. As with the device 10, these tabs leave the backing layer of the D-tabs 162 in place when the backing is removed from the body 120.
The yoke 124 is substantially identical in shape to the yoke 24 of the device 10; however, the tabs in the neck 122 and yoke 124 of the device 110 are altered relative to the device 10. In the device 110, the yoke 124 is provided with a back cut 190 which is generally perpendicular to the bottom edge 138 of the yoke arm and which extends across one of the yoke arms 136 to divide the backing layer of the yoke into at least two portions. A bottom ply tab 192 (labeled C3) extends from the edge 134 of the neck 122 above the back cut 184. The inner edge of the tab 192 is defined by a top-middle cut 192a, such that when the C3-tab 192 is pulled, it will remove the backing layer from the middle ply between the cuts 184 and 190. A bottom ply tab 194 (labeled C4) extends from the edge 138 of the yoke arm 136 at or above the cut line 190. The inner edge of the tab 194 is defined by a top-middle cut 194a, such that when the C4-tab 194 is pulled, it will remove the backing layer from the middle ply of the arm 136 above the cut 190. Thus, the backing ply of the neck and yoke are removed from the middle ply using the C3- and C4-tabs 192 and 194. The C3-tab 192 removes the backing layer from the neck 122 and yoke 124 (except for the upper portion of one of the yoke arms 136); and the C4-tab 194 removes the backing ply from the upper portion of the yoke arm. The device 110 is shown with a C4-tab 194 on only one yoke arm 136. If desired, the other yoke arm could be provided with a back cut corresponding to the back cut 190 and a second C4-tab, such that the backing ply for the upper portions of both yoke arms is removed independently of the backing ply for the neck and lower portion of the yoke.
As noted above, the retractor/wound exposure device 110 is intended to be applied to the patient starting with the body 120, rather than the yoke, of the device. The provision of the 01- and C2-tabs 186 and 188 allow for the device body 120 to be applied to the patient in essentially three sections (labeled as {circle around (1)}, {circle around (2)}, and {circle around (3)} in
Once the body 120 has been applied to the panniculus, the medical staff can pull the C3-tab 192 to expose the adhesive of the middle ply in the neck 122 and at least the lower portion of the yoke 124. With the panniculus still being held in the retracted position, the neck and at least the lower portion of the yoke are adhered to the patient between the patient's xiphoid process and an upper portion of the patient's thorax to anchor the device 110 to the patient. At this point, the device 110 will be self-supporting and will support and hold the panniculus in the retracted position. Lastly, the C4-tab 194 can be pulled to expose the adhesive in the upper portion of the arm having the tab (or in both arms if the device is provided with two C4-tabs), and the last, upper portion of the yoke can be adhered to the patient.
After the medical/surgical procedure has been completed, the top ply can be removed from the middle ply in the same manner as described above in conjunction with device 10 by pulling the D-tabs 162.
The device 410 (
In the devices 10, 110, the tabs which remove the bottom or backing ply do not overlap the tabs which remove the top ply (that is, they are spaced apart on the device). This requires additional space. In material in which the top and bottom plies extend relative to the middle ply, the tabs can overlap.
The tab styles TS1-TS3 allow for the tabs to be smaller than the tabs of the devices 10 and 110, and allow for a plurality of tabs to occupy a smaller length along an edge of the device. In addition, because the tabs are formed from the extended portion of the top and bottom plies (i.e., the portion of the top and bottom plies extending beyond the edge of the middle ply), top-middle cuts or bottom-middle cuts (as described in
The device 610 (
Additionally, the device 710 is provided with first and second top perforations 724 and 726, respectively. At least one D-tab is provided along a side of the middle section 720b and is associated with the top ply (by a bottom-middle cut at the inner end of the tab) such that the D-tabs operate to remove the top ply from the middle section in the area between the top perforations 724 and 726. In addition, a window 728 is formed between the perforated lines 724 and 726 by a through cut. The window (which is optional) can be provided to locally reduce the cross-sectional area to allow for stretch. This allows for adjusting the load lifting capability of the device.
In use, the bottom section 720a is initially applied to the patient. When applied, it bears a static load, and is not stretched. The static load area is defined by the lower area 730, defined by dashed lines. After the lower section 720a has been applied to the patient, the backing layer is removed from the middle section 720b by pulling on the C-tabs. With just the backing layer removed, the top ply will prevent the middle ply from stretching. However, if stretching is necessary during application of the device to a patient, the top ply strip between perforated lines 724 and 726 can be removed by pulling on the D-tab. This will expose a large strip or area of the middle ply, which can be stretched a desired amount. Once the middle section has been stretched and adhered to the patient, the backing layer can be removed from the top section 720c, and the top section can then be adhered to an anchor point on the patient.
As noted above, the bottom portion, identified by the dashed line 730 is subject to a static load. The central portion in which the top ply has been removed defines an area identified by the dashed line 732 which is subject to dynamic loads. The top section (which still has the top ply) defines an anchor attachment field load area, and is identified by the dashed line 734. When the device 710 is applied to the patient an imaginary theoretical load line 736 is effectively formed which extends through the bottom section and along which the forces are null. Below this null force line, linear forces are reduced, and above this null line, linear forces increase.
The device 810 is also shown to include a pair of spaced apart sinusoidal or wave shaped perforations 818. The wave or sinusoidal perforations 818 extend the width of the device. The upper wave perforation has trough bottoms 818b which are aligned with, or level with, the junction between mid-section 810b and the upper section 810c. The lower wave perforation has peaks 818a which are level or even with the junction between the mid-section 810b and the bottom section 810a. The wave perforations 818 are intended to reduce shear stresses on the patient's skin when the device is applied to the patient. The wave perforations 818 makes the shear line longer to reduce the concentrated adhesive area on the skin.
Additionally, the device 810 includes bottom ply A-tabs and D-tabs 822 which are formed and operable to remove the bottom ply (release liner) from the upper and bottom sections 810a,c. B-tabs 824 are formed and operable to remove the top ply from the device 810. Lastly, “press” down areas 826 (labeled “C”) are provided adjacent the B tabs. As discussed above, these press down areas can be used (pressed against) when the B-tabs are pulled, to reduce the possibility of the middle ply from lifting off the patient when the top ply is removed from the device.
A further retractor/wound exposure device 910 is shown generally in
As shown in
To form the multi-ply device with the middle ply cuts MC, the middle ply material is first adhered to the bottom ply. This can be accomplished by applying the gel adhesive to the middle ply material, and then laminating the bottom ply material to the middle ply material; or by applying the gel adhesive to the bottom ply material and then laminating the middle ply material to the bottom ply material. If either the middle ply material or the bottom ply material is supplied with the gel adhesive, then the coating step can be avoided. With the middle and bottom plies joined, the middle ply cuts MC, the bottom ply cuts BC and bottom-middle cuts BMC are formed. The top ply material is then laminated to the bottom-middle ply assembly. This is accomplished by coating one of the top ply or middle ply with the acrylate adhesive, and then laminating the top ply material to the middle-bottom ply assembly. If either the top ply or middle ply is provided (as is) with the acrylate adhesive, then this coating step can be avoided. Once the top ply is adhered to the middle ply, the top ply cuts TC and top-middle cuts TMC can be formed. At the same time, the overall device 910 can be cut from the remainder of the material. As an alternative method, the middle ply and top ply can be adhered together first, and then the bottom ply can be laminated to the middle ply. The cuts are all preferably formed by die-cutting.
With reference to
A pair of opposed C-tabs 942 extend from the side edges 926 between the bottom ply cuts 938 and 940. As shown, the bottom edges of the C-tabs are flush or even with the bottom ply cut 938. Additionally, a pair of D-tabs 944 extend from the upper lobes 928. As shown, the D-tabs extend downwardly and face the lower lobes 930. The A-, B-, C-, and D-tabs are all separated from the body of the device 910 by top-middle cuts 932a, 934a, 942a, and 944a, respectively. The bottom ply cuts 936 and 938 divide a bottom portion of the body bottom ply into a some-what T-shaped center portion 912a and two side lobes 912b, with the A-tab 932 being associated with the center portion 912a and the B-tabs 934 being associated with the two side lobes 912b. As can be appreciated from the discussion above, pulling of the A-tab 932 will remove the bottom ply portion 912a from the middle ply to expose the adhesive of the middle ply in this portion of the body; and pulling B-tabs will remove the bottom ply portions 912b from the middle ply to expose the adhesive of the middle ply in these sections.
The two bottom cuts 938 and 940 define a middle section 912c of the bottom ply with which the C-tabs 942 are associated. Pulling either C-tab will therefore remove the bottom ply portions 912c from the middle ply to expose the adhesive of the middle ply in this section.
Lastly, the portion 912d of the bottom ply between the bottom ply cut 940 and the top edge 922 of the device is associated with the D-tabs 944. Pulling the D-tabs removes the bottom ply portion 912d from the middle ply to expose the adhesive of the middle ply in this section.
A top ply cut 950 extends between the top edge 922 and bottom edge 924 of the device and effectively bi-sects that top ply of the device into two halves 916a and 916b. T1- and T2-tabs 952 and 954 extend from the top edge 922 of the device, and are separated from the body of the device by bottom-middle cuts 952a and 954a. The thus, the tabs 952 and 954 are co-extensive with, and are associated with, the top ply sections 916a and 916b, Hence, pulling the tabs 952 and 954 will pull the top ply sections 916a,b from the middle ply. Preferably, the adhesive will remain associated with the top ply, such that the exposed surface of the middle ply will be adhesive free, or at least non-tacky, when the top ply is removed. If desired, the top cut 950 could be omitted, and the top ply 916 could be removed from the middle ply as a single panel.
Lastly, the device 910 includes a middle cut 956 which extends between the side edges 926 of the device near the bottom edge 914. The middle cut 956 intersects the side edges generally at the top of the bottom lobes 930 and forms a generally downwardly curved arc.
The device 910 is preferably applied pre-operatively, in a bottom up fashion, much as described above in conjunction with the device 110. Initially, the A-tab is activated/pulled to remove the central portion 912a of the bottom ply from the device to expose the adhesive in this section. This central-lower section of the middle ply can then be applied to the patient by positioning the area on the panniculus (or other excess tissue) such that the bottom edge 924 of the device will be on the panniculus, and thus away from the intended incision site. This first section of the middle ply is then smoothed out over the patient's panniculus. The two side pieces 912b of the bottom ply are then removed by pulling the B-tabs. With the adhesive of the middle ply now exposed in the lower side portions, the side lower portions of the device can be smoothed over, and adhered to, the patient's panniculus.
After initial placement of the device in this manner, the device is folded over, and the C-tabs 942 are pulled to remove the middle panel 912c of the bottom ply from the middle ply, to expose the adhesive in this portion of the middle ply. This is accomplished with the middle portion of the device lifted or held away from the patient's skin. As can be appreciated, at this point in application of the device, the bottom ply portions 912d at the upper end of the device are still adhered to the middle ply, and thus, the top corners of the device, at this point, define grab or hand hold areas. This top portion of the device can then be used to pull the excess tissue (such as the panniculus) toward the anchor point. In a panniculus retraction, this would be in a cephalad direction relative to the patient. Because the top ply is relatively non-stretchy, the device will not stretch significantly, and the panniculus will be pulled away from the intended incision site to expose the intended incision site. When the panniculus has been pulled away from the incision site sufficiently, the middle portion of the middle ply can be applied to, and smoothed out over, the patient's skin. When the panniculus is released by the staff holding it in position, the device 910 will maintain the panniculus away from the incision site. At this point, the D-tabs can be pulled to remove the upper portion 912d of the bottom ply from the middle ply, and the top portion of the middle ply can be applied to the patient.
At this point, the bottom ply has been fully removed from the device, and the middle ply is adhered to the patient over the full extent of the middle ply, and the top ply remains on the middle ply. As noted above, the top ply is substantially non-stretchable, and hence, the top ply will prevent the panniculus from relaxing to a position in which the incision site is not accessible. Hence, the desired medical or surgical procedure can be carried out on the patient.
Once the procedure has been completed, it is desirable to maintain the panniculus away from the incision site to allow the incision to heal. As can be appreciated, if the panniculus was allowed to relax fully after the procedure, the incision site would be covered, air likely would not be able to flow to the incision site, and healing of the incision would be hampered. The device 910 can be worn long term (for several days or even weeks) to maintain the panniculus or other retracted excess tissue in a retracted position relative to the incision site.
The top ply is preferably air and water impermeable, but the middle ply is at least air permeable. The top ply is thus preferably removed from the middle ply after the procedure has been completed. The top ply is removed in two sections, 916a and 916b, using the T1- and T2-tabs 952 and 954. As noted above, there is a middle ply cut 956 at the bottom of the device. Thus, as the top ply is removed using the T1 and T2 tabs, the bottom portion 914a of the middle ply will be removed from the patient as well. The acrylic adhesive 915 is stronger than the gel adhesive 913 such that the bottom portion 914a of the middle ply will remain with the top ply as the top ply is removed. When the top ply is removed, all that will remain on the patient is the middle ply (less the bottom portion 914a of the middle ply). Removal of this bottom portion of the middle ply is intended to make the device more comfortable to wear for longer periods of time.
When the top ply is removed from the middle ply, the middle ply will be allowed to stretch according to its own stretch properties. However, the middle ply is not so stretchy that the patient's panniculus will fully relax. Even without the top ply, the middle ply will hold the panniculus away from the incision site to allow the incision to heal.
As noted above, the middle ply is adhered to the patient by a gel adhesive (preferably a silicone gel adhesive). Unlike a dry adhesive (such as the acrylate adhesive 915 which adheres the top ply to the middle ply), the gel adhesive protects the dermis from shear forces by accumulating the forces. Thus, forces that are transferred to the middle ply (which remains on the patient), for example, by the weight of the panniculus) are not transferred to the patient's dermis by the yielding properties of the gel adhesive. Dry adhesives, such as the acrylate adhesive 915 do not yield.
A variation of the device 910 is shown in
In addition, the device 910′ includes a vertical bottom cut 940a which extends from the approximate middle of the bottom cut 940 to the top edge 922′ of the device 910′. Thus, the two D-tabs will each remove one-half of the top portion of the bottom ply during application of the device to a patient.
Any of the above described devices can be provided with sensors or indicators to monitor and inform of, for example, changes in elongation and/or stretch of the device. Additionally, the device may include one or more sensor boards (including sensors) that monitors/collect and transmit data relative to ambient and physiological aspects of the patient's wound. For example, such sensors can monitor/detect the presence of biological (i.e., bacterial or viral) agents, physiological data (i.e., blood pressure, skin temperature at the incision site, heart rate), or concentrations of specific chemicals, vapors or gases (such as H2O, O2 or CO2). Such sensors could also monitor the stretch/elongation of the retractor/stabilizer. Sensors and indicators which monitor elongation and/or stretch of the retractor/stabilizer can be placed anywhere on the device, and be used to monitor the stretch/elongation of the device in a direction of the tension of the device. This stretch direction could be, but is not necessarily, parallel to the machine direction of the device. Proposed locations for sensors/indicators are shown in
An indicator/sensor which monitors or responds to elongation/stretch will provide an indication if the device exceeds more than a predetermined amount (percentage) of its maximum elongation/stretch. As can be appreciated, this can be beneficial during application of the device to the patient. Additionally, if the device is to be worn long term (i.e., for days, or even weeks), for example, after the top ply has been removed, an stretch/elongation indicator/sensor can determine if undue stresses are placed on the device which could affect the ability of the device to maintain the panniculus in a retracted position (and off a wound).
An indicator/sensor which monitors or measures ambient and physiological aspects of the patient's wound is preferably positioned on the device so as to be proximate the incision site. These indicators/sensors can be applied to the device after application of the device to the patient, or the device can be supplied with the sensor(s) already positioned on the device. Such an indicator/sensor would provide a notification if the monitored parameter exceeds or falls below a predetermined threshold. This can be relevant during a procedure. However, it can be more relevant if the device is worn long term. A rise in temperature or an increase in bacterial or viral activity can denote the infection has set in, or is setting in, at or around the incision site. A drop in O2 levels or an increase in H2O levels could indicate that the incision site is not receiving enough air.
The stretch indicator can be mechanical, or as noted, incorporated in an electrical sensor. The sensor used in association with wound care is positioned to collect/monitor/assemble data relative to ambient conditions and physiological aspects of the patient and transmit the data to a receiver. The receiver can be a dedicated receiver or an application (app) on a personal device (tablet computer, mobile phone, etc.). Data collected is evaluated by the receiver to monitor ambient conditions at the incision site to determine the conditions at the incision site (wound).
If sensors are used, the device will be provided with a power source for the sensors. The sensors are wired or wireless and can be integrated into the device or placed in close proximity to the target site (either prior to or after the device has been applied the patient). The signal from the sensor will be received by a monitor/receiver which will interpret the signal. The monitor can, for example, be a personal device provided with an application (app) adapted to receive the signal from the sensor via, for example, blue tooth connectivity, or any other type of wireless connectivity. Alternatively, the monitor can be a dedicated monitor. The monitor can issue a visual, tactile (vibratory) or audible alert if the monitored parameter falls out of predetermined bounds. In addition to notifying the patient of an out of bounds parameter, the monitor can send a signal to a practitioner, so that the practitioner can receive warning of the out-of-bound condition. The practitioner can then take appropriate corrective actions as may be necessary.
In view of the above, it can be seen that we have provided a device which can initially be used as a retractor to retract and stabilize excess flesh (such as a panniculus) during a medical/surgical procedure. Upon completion of the procedure, the top ply of the device can be removed, leaving only the middle, breathable ply adhered to the patient. This middle ply can be worn for extended periods of time to maintain the excess flesh away from any incision site or puncture wound, to allow for proper healing. Additionally, the device is provided with tab configurations which allow for the bottom ply to be separated from the middle ply without the need for medical staff to contact adhesive of the middle ply. Further, the tab configuration allows for the top ply to be removed from the middle ply while the middle ply is adhered to the patient while minimizing the risk of removing the middle ply from the patient. Finally, variations are provided which enable the device to stretch during application to the patient, such that the middle ply can be relied upon to maintain a pull on the excess flesh to maintain the excess flesh in the retracted position.
As various changes could be made in the above constructions without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense. For example, although the device is shown with external tabs (which extend from the edges of the device), the device could be provided with internal tabs, wherein the outer edge of the tabs are flush with the edge of the device.
This application is the US National Stage application of PCT/US2017/033593, filed May 19, 2017, which claims priority to U.S. App. No. 62/341,730 filed May 26, 2016 and entitled “Multi-Ply Retractor/Stabilizer And Wound Exposure Device For Use With Patients Having Excessive And/Or Redundant Tissue And Method Of Use”. Additionally, this application is related to U.S. Pat. No. 9,427,222 which is entitled “Retractor/Stabilizer For Excessive And/Or Redundant Tissue And Method Of Use,” and to International App. No. PCT/US2016/013404 (published as WO2016/122892) which is entitled “Wound Care Exposure Device For Use With Patients Having Excessive And/Or Redundant Tissue And Method Of Use.” All of said patents and applications are incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2017/033593 | 5/19/2017 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2017/205212 | 11/30/2017 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 1783512 | Mather | Dec 1930 | A |
| 3522800 | Lesser | Aug 1970 | A |
| 3826253 | Larsh et al. | Jul 1974 | A |
| 3859157 | Morgan | Jan 1975 | A |
| 4169472 | Morris | Oct 1979 | A |
| 4196723 | Moose, Jr. | Apr 1980 | A |
| 4432347 | Clavin | Feb 1984 | A |
| 4619253 | Anhauser et al. | Oct 1986 | A |
| 4621619 | Sharpe | Nov 1986 | A |
| 4825866 | Pierce | May 1989 | A |
| 4995383 | Andersson | Feb 1991 | A |
| 5234462 | Pavletic | Aug 1993 | A |
| 5259835 | Clark et al. | Nov 1993 | A |
| 5275177 | Wilk | Jan 1994 | A |
| 5516581 | Kreckel et al. | May 1996 | A |
| 5599289 | Castellana | Feb 1997 | A |
| 5611333 | Johnson | Mar 1997 | A |
| 5672402 | Kreckel et al. | Sep 1997 | A |
| 5891077 | Gilman et al. | Apr 1999 | A |
| 5985395 | Comstock et al. | Nov 1999 | A |
| 6200195 | Furuno et al. | Mar 2001 | B1 |
| 6350175 | Johnson et al. | Feb 2002 | B2 |
| 6383502 | Dunshee et al. | May 2002 | B1 |
| 6541089 | Hamerski et al. | Apr 2003 | B1 |
| 6814700 | Mueller et al. | Nov 2004 | B1 |
| 6857935 | Dohan | Feb 2005 | B1 |
| 7066182 | Dunshee | Jun 2006 | B1 |
| 7122236 | Mitchell et al. | Oct 2006 | B2 |
| 7374633 | Sellars | May 2008 | B2 |
| 7473158 | Horton | Jan 2009 | B2 |
| 7637798 | Lutzi | Dec 2009 | B2 |
| 7938121 | McKnight et al. | May 2011 | B2 |
| 9408741 | Blurton et al. | Aug 2016 | B2 |
| 20020191331 | Nonaka et al. | Dec 2002 | A1 |
| 20050150503 | Votel | Jul 2005 | A1 |
| 20060137262 | Crowder-Moore et al. | Jun 2006 | A1 |
| 20080103366 | Banchieri et al. | May 2008 | A1 |
| 20080210223 | Joines et al. | Sep 2008 | A1 |
| 20090264709 | Blurton et al. | Oct 2009 | A1 |
| 20100145155 | Sorajja | Jun 2010 | A1 |
| 20100318013 | Fabo et al. | Dec 2010 | A1 |
| 20110118646 | Marcoux et al. | May 2011 | A1 |
| 20110250375 | Bries et al. | Oct 2011 | A1 |
| 20120029295 | Long Sharps et al. | Feb 2012 | A1 |
| 20120143010 | Deasey et al. | Jun 2012 | A1 |
| 20120221044 | Archibald | Aug 2012 | A1 |
| 20120308754 | Dehlinger et al. | Dec 2012 | A1 |
| 20120312308 | Allen | Dec 2012 | A1 |
| 20130048203 | Yau et al. | Feb 2013 | A1 |
| 20130133668 | Fisher | May 2013 | A1 |
| 20160007980 | Galbierz et al. | Jan 2016 | A1 |
| 20190336233 | Galbierz et al. | Nov 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 0081987 | Oct 1985 | EP |
| 0051935 | Nov 1986 | EP |
| 0570317 | Nov 1993 | EP |
| 0638301 | Sep 1999 | EP |
| 0942940 | Jul 2002 | EP |
| 0971661 | Jan 2004 | EP |
| 0864311 | Oct 2004 | EP |
| 1944001 | Mar 2013 | EP |
| 9707760 | Mar 1997 | WO |
| 2003043822 | May 2003 | WO |
| 2014120746 | Aug 2014 | WO |
| 20140120746 | Aug 2014 | WO |
| 2015052288 | Apr 2015 | WO |
| Entry |
|---|
| International Search Report for corresponding PCT/2017/033593, dated Aug. 22, 2017 mailed. |
| Written Opinion for corresponding PCT/2017/033593, dated Aug. 22, 2017 mailed. |
| Extended European Search Report from corresponding EP Application No. 17803333.8 dated Dec. 16, 2019. |
| Number | Date | Country | |
|---|---|---|---|
| 20190159768 A1 | May 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62341730 | May 2016 | US |
